Y Ubara, S Hara, H Katori, T Tagami, A Kitamura, M Yokota, Y Matsushita, F Takemoto, A Yamada, K Nagahama, M Hara, K Chayama
Many patients with type II mixed cryoglobulinemia have been shown to be infected with hapatitis C virus (HCV). Therefore, interferon-alfa has become the first choice of treatment for patients with HCV-associated cryoglobulinemia. However, the disease often relapses after the discontinuation of interferon therapy. The long-term effect of interferon therapy is controversial. Therefore, a more effective therapy needs to be developed. A 62-year-old Japanese woman was admitted to our hospital for the examination of abnormal liver function tests, severe edema, and purpura in her lower extremities...
June 2000: American Journal of Kidney Diseases